NSI-189

NSI-189 · Neuralstem Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NSI-189, covering 2011-11-21 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of NSI-189 for Major Depressive Disorder [Phase 2]